7T82

Crystal Structure of LEUKOCIDIN E/CENTYRIN S26/FAB B438

7T82 の概要

• エントリーDOI: 10.2210/pdb7t82/pdb
• 分子名称: Leukocidin E, Antibody Fab Light Chain, Antibody Fab Heavy Chain, ... (4 entities in total)
• 機能のキーワード: staphylococcus aureus, sd repeat, phospho sd peptide, fab, cr5133, toxin
• 由来する生物種: Staphylococcaceae; 詳細
• タンパク質・核酸の鎖数: 8
• 化学式量合計: 184743.87

構造登録者

Luo, J.,Malia, T.J.,Buckley, P.T. (登録日: 2021-12-15, 公開日: 2023-01-11, 最終更新日: 2024-11-06)

主引用文献

Buckley, P.T.,Chan, R.,Fernandez, J.,Luo, J.,Lacey, K.A.,DuMont, A.L.,O'Malley, A.,Brezski, R.J.,Zheng, S.,Malia, T.,Whitaker, B.,Zwolak, A.,Payne, A.,Clark, D.,Sigg, M.,Lacy, E.R.,Kornilova, A.,Kwok, D.,McCarthy, S.,Wu, B.,Morrow, B.,Nemeth-Seay, J.,Petley, T.,Wu, S.,Strohl, W.R.,Lynch, A.S.,Torres, V.J.
Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infections.
Cell Host Microbe, 31:751-765.e11, 2023

PubMed Abstract: Treating and preventing infections by antimicrobial-resistant bacterial pathogens is a worldwide problem. Pathogens such as Staphylococcus aureus produce an array of virulence determinants, making it difficult to identify single targets for the development of vaccines or monoclonal therapies. We described a human-derived anti-S. aureus monoclonal antibody (mAb)-centyrin fusion protein ("mAbtyrin") that simultaneously targets multiple bacterial adhesins, resists proteolysis by bacterial protease GluV8, avoids Fc engagement by S. aureus IgG-binding proteins SpA and Sbi, and neutralizes pore-forming leukocidins via fusion with anti-toxin centyrins, while maintaining Fc- and complement-mediated functions. Compared with the parental mAb, mAbtyrin protected human phagocytes and boosted phagocyte-mediated killing. The mAbtyrin also reduced pathology, reduced bacterial burden, and protected from different types of infections in preclinical animal models. Finally, mAbtyrin synergized with vancomycin, enhancing pathogen clearance in an animal model of bacteremia. Altogether, these data establish the potential of multivalent mAbs for treating and preventing S. aureus diseases.

PubMed: 37098341
DOI: 10.1016/j.chom.2023.04.004

実験手法

X-RAY DIFFRACTION (3.5 Å)